Published in
Elsevier, Molecular Genetics and Metabolism Reports, (28), p. 100772, 2021
DOI: 10.1016/j.ymgmr.2021.100772
Links
Tools
A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1
Journal article published in 2021 by
Margaret Reynolds,
Laura A. Linneman,
Sofia Luna,
Barbara B. Warner,
Yumirle P. Turmelle,
Sakil S. Kulkarni 
,
Xuntian Jiang,
Geetika Khanna,
Marwan Shinawi,
Forbes D. Porter,
Daniel S. Ory,
F. Sessions Cole,
Patricia I. Dickson
,
Xuntian Jiang,
Geetika Khanna,
Marwan Shinawi,
Forbes D. Porter,
Daniel S. Ory,
F. Sessions Cole,
Patricia I. Dickson
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 